ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy

AstraZeneca · 2006
ClinicalTrials.gov · Datasets · License: Public Domain · 2006
Open Source ↗
pancreatic-cancer
pancreatic cancer, advanced pancreatic cancer, metastatic pancreatic cancer, azd6244, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 894218
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.